Market revenue in 2024 | USD 27.8 million |
Market revenue in 2030 | USD 65.1 million |
Growth rate | 15.2% (CAGR from 2025 to 2030) |
Largest segment | Exocrine |
Fastest growing segment | Endocrine |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Exocrine, Endocrine |
Key market players worldwide | Accuray Inc, AstraZeneca PLC ADR, Novartis AG ADR, Pfizer Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Ipsen Pharma, Eli Lilly and Co, Siemens Healthineers AG ADR, Elekta AB ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer treatment market will help companies and investors design strategic landscapes.
Exocrine was the largest segment with a revenue share of 88.49% in 2024. Horizon Databook has segmented the Mexico pancreatic cancer treatment market based on exocrine, endocrine covering the revenue growth of each sub-segment from 2018 to 2030.
The pancreatic cancer treatment market in Mexico is expected to experience steady growth, driven by the rising incidence of the disease and advancements in treatment options. According to WH, in 2024, around 5,822 new cases of pancreatic cancer were reported in Mexico.
Despite a lower incidence compared to other cancers, pancreatic cancer remains one of the most lethal, with a five-year survival rate of only about 10%. Chemotherapy is the primary treatment modality, with common regimens including gemcitabine and nab-paclitaxel.
particularly for advanced stages. Adopting targeted therapies and immunotherapies is expected to expand, given their potential for more personalized treatment with fewer side effects. Hospitals are forecast to account for a significant.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico pancreatic cancer treatment market , including forecasts for subscribers. This country databook contains high-level insights into Mexico pancreatic cancer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account